FDA announced a virtual VRBPAC meeting to discuss the Pfizer-BioNTech supplemental application for a third (“booster”) dose of Comirnaty (COVID-19 Vaccine, mRNA).
Read more: FDA In Brief: FDA to Hold Advisory Committee Meeting to Discuss Pfizer-BioNTech’s Application for COVID-19 Booster